Healthcare

The share price was AUD 32.04 during theTrading sessionon 17 September 2026. The stock moved up by 0.44% during the trading session on 17 September 2026.

The microbiome health company, which develops and markets evidence-based probiotics and complementary medicines, said the launches target a segment of the Australian pharmacy market currently dominated by competitors' larger pack sizes.

Compumedics Ltd (ASX:CMP) is an Australian healthcare technology company focused on developing and supplying diagnostic systems for sleep disorders, neurological conditions and brain monitoring applications. The company operates within the medical technology sector, providing solutions used by healthcare professionals and research organisations.

Argenica Therapeutics Ltd (ASX:AGN) is an Australian biotechnology company focused on developing neuroprotective therapeutics. ItsResearch and Developmentactivities are directed toward potential treatments intended to protect brain tissue following neurological injury, placing clinical development and scientific validation at the centre of the company’s progress.

BlinkLab Ltd (ASX:BB1) is an Australian healthcare technology company focused on developing digital neurodiagnostic solutions. The company’s platform uses digital assessments designed to support the evaluation of neurological and behavioural conditions.

Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian biotechnology company focused on developing synthetic anti-infective therapies designed to address bacterial infections. The company’s activities centre on research, clinical development and advancing its therapeutic pipeline.

Propel Funeral Partners Ltd (ASX:PFP) is a healthcare services company operating funeral homes, cemeteries and related services across Australia and New Zealand. The company’sBusinessmodel is focused on providing essential funeral services through a network of locations and brands.